(ALB) Albemarle - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0126531013
ALB: Lithium, Bromine, Catalysts, Chemicals, Energy, Solutions
Albemarle Corporation (NYSE: ALB) is a global leader in the development, manufacturing, and marketing of specialized chemicals. With a rich history dating back to 1887, the company has positioned itself as a critical player in multiple high-growth industries. Its operations are divided into three key segments: Energy Storage, Specialties, and Ketjen.
The Energy Storage segment is pivotal, focusing on lithium compounds essential for renewable energy and electric vehicle (EV) technologies. Products include lithium carbonate and hydroxide, crucial for EV batteries. Additionally, the segment offers recycling services for lithium by-products, enhancing sustainability in the energy sector.
The Specialties segment diversifies the companys portfolio with bromine-based chemicals, used in fire retardants and pharmaceuticals, and cesium products for the chemical industry. This segment underscores Albemarles commitment to innovation and industrial applications.
The Ketjen segment specializes in clean fuels technologies, including catalysts for petroleum refining. This segment addresses the growing demand for efficient refining processes, aligning with global efforts to reduce emissions and improve fuel quality.
With a market cap of over $9.3 billion, Albemarles financials indicate a forward P/E ratio of 71.94, reflecting investor confidence in its growth prospects. This, coupled with a diversified market approach, positions Albemarle as a strategic investment opportunity in the specialty chemicals sector.
Additional Sources for ALB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ALB Stock Overview
| Market Cap in USD | 8,488m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Specialty Chemicals |
| IPO / Inception | 1994-02-17 |
ALB Stock Ratings
| Growth 5y | -4.83% |
| Fundamental | -42.7% |
| Dividend | 54.3% |
| Rel. Strength | -40.4 |
| Analysts | 3.57/5 |
| Fair Price Momentum | 61.52 USD |
| Fair Price DCF | - |
ALB Dividends
| Dividend Yield 12m | 1.95% |
| Yield on Cost 5y | 3.24% |
| Annual Growth 5y | 0.89% |
| Payout Consistency | 97.2% |
ALB Growth Ratios
| Growth Correlation 3m | -81.9% |
| Growth Correlation 12m | -68.3% |
| Growth Correlation 5y | -9.9% |
| CAGR 5y | 7.57% |
| CAGR/Max DD 5y | 0.10 |
| Sharpe Ratio 12m | -1.35 |
| Alpha | -55.42 |
| Beta | 1.704 |
| Volatility | 47.42% |
| Current Volume | 2010.1k |
| Average Volume 20d | 2009.9k |
As of April 02, 2025, the stock is trading at USD 71.82 with a total of 2,010,065 shares traded.
Over the past week, the price has changed by -7.53%, over one month by +3.25%, over three months by -15.26% and over the past year by -43.40%.
Probably not. Based on ValueRay Fundamental Analyses, Albemarle (NYSE:ALB) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -42.73 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALB as of April 2025 is 61.52. This means that ALB is currently overvalued and has a potential downside of -14.34%.
Albemarle has received a consensus analysts rating of 3.57. Therefor, it is recommend to hold ALB.
- Strong Buy: 8
- Buy: 3
- Hold: 15
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, ALB Albemarle will be worth about 68.8 in April 2026. The stock is currently trading at 71.82. This means that the stock has a potential downside of -4.26%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 101.3 | 41.1% |
| Analysts Target Price | 117.9 | 64.1% |
| ValueRay Target Price | 68.8 | -4.3% |